Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/29/22 17:12 | 6/28/22 | TRVN | Health | Drug | Pharmaceutical Preparations | Shin Barry | PA | O | SVP,CFO | S | -13 | 0.4100 | 0 | -32 | -4 | 873 | D | ||||||||||||||
3/23/18 17:16 | 3/22/18 | TRVN | Health | Drug | Pharmaceutical Preparations | Habib Yacoub | PA | O | SVP,Bus | S | -9 | 1.76 | 0 | -5 | -100 | 0 | D | ||||||||||||||
12/11/15 17:17 | 12/10/15 | TRVN | Health | Drug | Pharmaceutical Preparations | Soergel David | PA | O | SVP,Clin | S | -287 | 10.55 | 5 | -27 | -94 | 2 | D | 161 | 62 | 4 | 8 | -9 | -12 | -6 | -1 | -1 | -20 | -25 | -36 | -44 | |
10/1/14 16:48 | 9/29/14 | TRVN | Health | Drug | Pharmaceutical Preparations | Deegan Rosamond | PA | O | SVP,Bus | S | 0 | 7.00 | 0 | 0 | 0 | 31 | D | -15 | 10 | 5 | 7 | 8 | 9 | 1 | 0 | -8 | 1 | 22 | 69 | ||
8/18/14 16:30 | 8/14/14 | TRVN | Health | Drug | Pharmaceutical Preparations | Polaris Venture Management Co. V, L.L.C. | MA | T | S | -222 | 6.04 | 0 | -37 | -50 | 36 | I | -5 | 46 | 17 | 20 | 9 | 2 | -6 | -8 | -13 | -13 | -19 | 2 | |||
8/15/14 16:30 | 8/13/14 | TRVN | Health | Drug | Pharmaceutical Preparations | Polaris Venture Management Co. V, L.L.C. | MA | T | S | -35 | 6.12 | 0 | -6 | -13 | 37 | I | -17 | 25 | 7 | 6 | -1 | 0 | 0 | -7 | -13 | -14 | -18 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |